| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adaptation of the intact proviral DNA assay to a nanowell-based digital PCR platform
|
Tumpach, Carolin
|
|
|
9 |
2 |
p.
|
article
|
| 2 |
Antigen specificities of HIV-infected cells: A role in infection and persistence?
|
Faua, Clayton
|
|
|
9 |
2 |
p.
|
article
|
| 3 |
Antiviral activity of silver nanoparticles against the influenza A virus
|
Naumenko, Krystyna
|
|
|
9 |
2 |
p.
|
article
|
| 4 |
Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 helicase inhibitors: a systematic review of in vitro studies
|
Mehyar, Nimer
|
|
|
9 |
2 |
p.
|
article
|
| 5 |
Editorial Board
|
|
|
|
9 |
2 |
p.
|
article
|
| 6 |
Editorial JVE 9.2
|
|
|
|
9 |
2 |
p.
|
article
|
| 7 |
Highlights of the first edition of the European Conference on Microbiota & Virology: A hybrid event, Paris, 23 March 2023
|
Psomas, Christina K.
|
|
|
9 |
2 |
p.
|
article
|
| 8 |
HIV remission trial investigators’ attitudes towards risk and risk mitigation in trials that include treatment interruption
|
Okumu, Eunice Akinyi
|
|
|
9 |
2 |
p.
|
article
|
| 9 |
Perceived risks and benefits of enrolling people with HIV at the end of life in cure research in Southern California, United States
|
Dubé, Karine
|
|
|
9 |
2 |
p.
|
article
|
| 10 |
Rate of occult hepatitis B virus infection among individuals with tuberculosis in northeastern Iran: A molecular epidemiological study
|
Ahmadi Ghezeldasht, Sanaz
|
|
|
9 |
2 |
p.
|
article
|
Journal description